loading
Dr Reddys Laboratories Ltd Adr stock is traded at $13.79, with a volume of 1.94M. It is down -1.50% in the last 24 hours and up +2.53% over the past month. Dr. Reddy's is one of the largest generic drug manufacturers in the world. It has a significant presence in North America, a region that makes up roughly half of its generics sales, and it services India (about 20% of its generics sales), Russia (10%), and certain European and Latin American countries. Beyond simple generics, Dr. Reddy's also has a solid portfolio of injectables which make up 25% of its North America sales. In branded generic markets like India, Dr. Reddy's has established a compelling presence with its strong brand name and earned a top five spot in key therapeutic areas including oncology and gastroenterology. Dr. Reddy's also has an active pharmaceutical ingredient business that manufactures over 150 APIs and sells in over 75 countries.
See More
Previous Close:
$14.00
Open:
$13.74
24h Volume:
1.94M
Relative Volume:
0.99
Market Cap:
$2.30B
Revenue:
$3.47B
Net Income/Loss:
$668.83M
P/E Ratio:
3.4366
EPS:
4.0127
Net Cash Flow:
$253.46M
1W Performance:
+0.88%
1M Performance:
+2.53%
6M Performance:
-9.73%
1Y Performance:
-6.85%
1-Day Range:
Value
$13.70
$13.83
1-Week Range:
Value
$13.59
$14.02
52-Week Range:
Value
$12.26
$16.89

Dr Reddys Laboratories Ltd Adr Stock (RDY) Company Profile

Name
Name
Dr Reddys Laboratories Ltd Adr
Name
Phone
-
Name
Address
-
Name
Employee
27,048
Name
Twitter
@drreddys
Name
Next Earnings Date
2025-01-23
Name
Latest SEC Filings
Name
RDY's Discussions on Twitter

Compare RDY with other stocks

Stocks Price Market Cap Revenue Net Income Cash Flow EPS
Drug Manufacturers - Specialty & Generic icon
RDY
Dr Reddys Laboratories Ltd Adr
13.79 2.30B 3.47B 668.83M 253.46M 4.0127
Drug Manufacturers - Specialty & Generic icon
ZTS
Zoetis Inc
153.47 65.50B 9.26B 2.49B 2.30B 5.47
Drug Manufacturers - Specialty & Generic icon
TAK
Takeda Pharmaceutical Co Adr
15.03 46.99B 30.25B 1.37B 5.08B 0.4257
Drug Manufacturers - Specialty & Generic icon
HLN
Haleon Plc Adr
10.18 45.96B 14.35B 1.85B 0 0.4023
Drug Manufacturers - Specialty & Generic icon
TEVA
Teva Pharmaceutical Industries Ltd Adr
14.87 17.04B 16.54B -1.64B 749.00M -1.45
Drug Manufacturers - Specialty & Generic icon
UTHR
United Therapeutics Corp
291.38 12.77B 2.76B 1.11B 898.10M 22.77

Dr Reddys Laboratories Ltd Adr Stock (RDY) Upgrades & Downgrades

Date Action Analyst Rating Change
Dec-19-24 Downgrade Nomura Buy → Neutral
Jan-11-24 Downgrade Jefferies Buy → Underperform
Aug-29-23 Downgrade HSBC Securities Buy → Hold
May-18-23 Downgrade Bernstein Outperform → Mkt Perform
Mar-17-23 Upgrade BofA Securities Neutral → Buy
Jan-30-23 Initiated JP Morgan Underweight
Nov-14-22 Downgrade Credit Suisse Neutral → Underperform
Jan-03-22 Resumed BofA Securities Neutral
Jul-27-21 Downgrade Credit Suisse Outperform → Neutral
Feb-02-21 Upgrade Barclays Equal Weight → Overweight
Sep-18-20 Upgrade BofA Securities Neutral → Buy
Sep-18-20 Upgrade Investec Sell → Hold
Jan-28-20 Downgrade CLSA Buy → Outperform
Jan-27-20 Downgrade CLSA Buy → Outperform
Jan-09-20 Upgrade Citigroup Sell → Buy
Nov-04-19 Downgrade BofA/Merrill Buy → Neutral
Sep-04-19 Upgrade Credit Suisse Underperform → Outperform
Jul-01-19 Upgrade Macquarie Neutral → Outperform
Jun-20-19 Initiated Deutsche Bank Hold
Jun-11-19 Initiated Barclays Equal Weight
May-20-19 Downgrade Morgan Stanley Overweight → Equal-Weight
Feb-19-19 Upgrade CLSA Outperform → Buy
Jan-17-19 Downgrade Citigroup Neutral → Sell
Sep-21-17 Upgrade Morgan Stanley Equal-Weight → Overweight
Aug-31-17 Upgrade CLSA Underperform → Outperform
Jul-28-17 Downgrade CLSA Underperform → Sell
Jul-27-16 Downgrade HSBC Securities Hold → Reduce
Jul-27-16 Downgrade Jefferies Hold → Underperform
Feb-10-16 Upgrade Credit Agricole Underperform → Buy
Nov-10-15 Downgrade Citigroup Buy → Neutral
View All

Dr Reddys Laboratories Ltd Adr Stock (RDY) Latest News

pulisher
Apr 25, 2025

Dr. Reddy’s Laboratories Ltd. ADR (RDY) Performance and Fundamentals Dashboard tells a completely different story - Sete News

Apr 25, 2025
pulisher
Apr 25, 2025

Asian ADRs See Mixed Results Despite Weekly Gains - Finimize

Apr 25, 2025
pulisher
Apr 24, 2025

Dr. Reddy’s Looks Well Positioned for Long-Term Growth, Aided by Acquisitions and Partnerships - Morningstar

Apr 24, 2025
pulisher
Apr 23, 2025

Investing in Dr. Reddy’s Laboratories Ltd. ADR (RDY): What You Must Know - knoxdaily.com

Apr 23, 2025
pulisher
Apr 20, 2025

LLY Stock Quote Price and Forecast - CNN

Apr 20, 2025
pulisher
Apr 17, 2025

NVO Stock Quote Price and Forecast - CNN

Apr 17, 2025
pulisher
Apr 16, 2025

Zacks Industry Outlook Dr. Reddy's, Sandoz And Teva Pharmaceuticals - Barchart.com

Apr 16, 2025
pulisher
Apr 15, 2025

Asian ADRs Climb, Showcasing North And South Asia Performances - Finimize

Apr 15, 2025
pulisher
Apr 14, 2025

PDD Holdings Stock Delivers Phenomenal 5.82% Surge to $95.77 on April 14 – Bullish Momentum Lifts Chinese Tech - Hindustan Herald

Apr 14, 2025
pulisher
Apr 14, 2025

3 Generic Drug Stocks To Watch Amid Trade War Jitters & Inflation Woes - Barchart.com

Apr 14, 2025
pulisher
Apr 12, 2025

Dr. Reddy's Laboratories Limited (NYSE:RDY) Shares Acquired by Massachusetts Financial Services Co. MA - MarketBeat

Apr 12, 2025
pulisher
Apr 11, 2025

Asian ADRs Shine As Zai Lab And CNFinance Lead The Gains - Finimize

Apr 11, 2025
pulisher
Apr 11, 2025

Asian Equities Traded in the US as American Depositary Receipts Rise in Friday Trading - TradingView

Apr 11, 2025
pulisher
Apr 11, 2025

Mixed Performance For Asian Stocks Traded On US Markets - Finimize

Apr 11, 2025
pulisher
Apr 11, 2025

Grantham Mayo Van Otterloo & Co. LLC Has $5.67 Million Position in Dr. Reddy's Laboratories Limited (NYSE:RDY) - MarketBeat

Apr 11, 2025
pulisher
Apr 10, 2025

Asian Equities Traded in the US as American Depositary Receipts Tumble in Thursday Trading - TradingView

Apr 10, 2025
pulisher
Apr 09, 2025

Pinpoint Asset Management Ltd Acquires 473,000 Shares of Dr. Reddy's Laboratories Limited (NYSE:RDY) - MarketBeat

Apr 09, 2025
pulisher
Apr 07, 2025

Asian Equities Traded in the US as American Depositary Receipts Sharply Lower in Monday Trading - TradingView

Apr 07, 2025
pulisher
Apr 06, 2025

Stocks to watch, April 7: IT, pharma, metals, oil-sensitive stocks, Nykaa, Dr Reddy's, Delhivery, Trent Ltd, and more - Upstox

Apr 06, 2025
pulisher
Apr 05, 2025

Dr Reddy's gets over Rs 2,395 crore show cause notice from I-T authority - Moneycontrol

Apr 05, 2025
pulisher
Apr 03, 2025

Asian Equities Traded in the US as American Depositary Receipts Fall in Thursday Trading - TradingView

Apr 03, 2025
pulisher
Apr 02, 2025

Asian Equities Traded in the US as American Depositary Receipts Trending Lower in Wednesday Trading - TradingView

Apr 02, 2025
pulisher
Apr 02, 2025

Generics Industry: India Celebrates Pharmaceutical Tariffs Exemption but Uncertainty Remains High - Morningstar

Apr 02, 2025
pulisher
Apr 01, 2025

US Tariffs on Pharma: Zydus, Dr Reddy’s at highest risk, says Jefferies; Check impact on other Indian pharma stocks - Mint

Apr 01, 2025
pulisher
Mar 29, 2025

Dr. Reddy's Laboratories Limited (NYSE:RDY) Shares Acquired by GQG Partners LLC - MarketBeat

Mar 29, 2025
pulisher
Mar 27, 2025

American Healthcare REIT Inc (AHR) Stock: A Year of Decreases and Increases - The InvestChronicle

Mar 27, 2025
pulisher
Mar 27, 2025

Asian Equities Traded in the US as ADRs Rise in Tuesday Trading - MSN

Mar 27, 2025
pulisher
Mar 25, 2025

Asian Equities Traded in the US as American Depositary Receipts Decline in Tuesday Trading - TradingView

Mar 25, 2025
pulisher
Mar 24, 2025

Weekly Stock Grader Analysis: Upgrades & Downgrades on Top Blue-Chip Stocks - InvestorPlace

Mar 24, 2025
pulisher
Mar 21, 2025

Asian Equities Traded in the US as American Depositary Receipts Lower in Friday Trading - TradingView

Mar 21, 2025
pulisher
Mar 20, 2025

Infosys, Wipro, TCS, other IT stocks fall up to 3% after Accenture Q2 results. Details here - Mint

Mar 20, 2025
pulisher
Mar 20, 2025

Infosys, Wipro ADRs drop over 3% on NYSE after Accenture hikes full-year revenue guidance to 5-7% on AI boom - Mint

Mar 20, 2025
pulisher
Mar 20, 2025

Asian Equities Traded in the US as American Depositary Receipts Decline in Thursday Trading - TradingView

Mar 20, 2025
pulisher
Mar 19, 2025

Asian Equities Traded in the US as American Depositary Receipts Rise Slightly in Wednesday Trading - TradingView

Mar 19, 2025
pulisher
Mar 18, 2025

Asian Equities Traded in the US as American Depositary Receipts Track Sharply Lower in Tuesday Trading - TradingView

Mar 18, 2025
pulisher
Mar 18, 2025

FDA accepts Dr. Reddy’s biosimilar application for bone drugs By Investing.com - Investing.com India

Mar 18, 2025
pulisher
Mar 17, 2025

Asian Equities Traded in the US as American Depositary Receipts Open Week Sharply Higher - TradingView

Mar 17, 2025
pulisher
Mar 13, 2025

Bioengineered Protein Drugs Market Size to Cross USD 672.7 Billion by 2034, Growing at a CAGR of 6.2% - GlobeNewswire Inc.

Mar 13, 2025
pulisher
Mar 13, 2025

Asian Equities Traded in the US as American Depositary Receipts Lower in Thursday Trading - TradingView

Mar 13, 2025
pulisher
Mar 12, 2025

Asian Equities Traded in the US as American Depositary Receipts Rise in Wednesday Trading - TradingView

Mar 12, 2025
pulisher
Mar 11, 2025

Asian Equities Traded in the US as American Depositary Receipts Higher in Tuesday Trading - TradingView

Mar 11, 2025
pulisher
Mar 07, 2025

Asian Equities Traded in the US as American Depositary Receipts Rise in Friday Trading, Up 1.5% for Week - TradingView

Mar 07, 2025
pulisher
Mar 06, 2025

Is TG Therapeutics Inc (NASDAQ: TGTX) A Good Investment For New Investors Now? - Stocks Register

Mar 06, 2025
pulisher
Mar 04, 2025

Senores Pharmaceuticals to acquire 14 ANDAs from Dr Reddy's - Business Standard

Mar 04, 2025
pulisher
Mar 01, 2025

Rhumbline Advisers Grows Position in Dr. Reddy's Laboratories Limited (NYSE:RDY) - MarketBeat

Mar 01, 2025
pulisher
Feb 27, 2025

Dr. Reddy's Laboratories Ltd. Sponsored ADR to Host Earnings Call - ACCESS Newswire

Feb 27, 2025
pulisher
Feb 27, 2025

Stocks to watch: Bharti Airtel, Wipro, Coforge, Dr Reddy’s, Vakrangee among shares to remain in focus today - Mint

Feb 27, 2025

Dr Reddys Laboratories Ltd Adr Stock (RDY) Financials Data

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading
$9.46
price up icon 0.00%
$27.84
price up icon 0.61%
$101.77
price down icon 1.80%
$8.13
price up icon 1.25%
$106.73
price up icon 0.92%
$291.38
price down icon 1.70%
Cap:     |  Volume (24h):